Technology | July 12, 2011

Boston Scientific Launchs Interlock-35 Fibered IDC Occlusion System

July 12, 2011 – The Interlock-35 Fibered IDC Occlusion System has been launched in the United States and Europe. Earlier this year, the system, manufactured by Boston Scientific, received clearance from the U.S. Food and Drug Administration (FDA) and CE mark approval for obstructing or reducing blood flow in the peripheral vasculature during embolization procedures. The Interlock-35 system consists of a 0.035-inch detachable coil that features a unique interlocking connection between the coil and delivery wire designed to offer excellent placement control, including the ability to advance, retract and reposition the coil before final deployment in the vessel. The coil is engineered to be accurately and reliably detached by simply pushing the detachment zone beyond the distal end of the 5 French delivery catheter. The platinum coil is constructed with a dense network of synthetic fibers, designed to offer excellent thrombogenicity (blockage of blood flow) and rapid stasis. "Compatibility with 5 French catheters allows for placement of larger coils, which can help achieve peripheral embolization with fewer coils, potentially reducing procedure times," said Sally Mitchell, M.D., professor of radiology, surgery and pediatrics at The Johns Hopkins University School of Medicine in Baltimore, Md. "The Interlock-35 coil provides excellent occlusive power while allowing precise retrievable placement, representing a major advantage over standard 0.035-inch pushable coil technology." The Interlock-35 Fibered IDC Occlusion System is available in 31 configurations that include coil lengths from 4 to 40 cm, diameters from 3 to 20 mm, and three distinct shapes (cube, 2-D helical and diamond) to offer physicians greater flexibility to treat diverse vessel anatomy. When combined with Boston Scientific's 0.018-inch Interlock Fibered IDC coils, the Interlock Coil portfolio provides 50 different coils to optimize peripheral embolization procedures. The company says the coil's user-friendly interlocking arms provide excellent control during deployment and detachment. The dense network of fibers provides rapid thrombosis, and the availability of larger and longer coils aid in effective vessel occlusion. For more information:

Related Content

Medtronic Launches Concerto 3-D Detachable Coil System
News | Embolization devices | October 16, 2017
October 16, 2017 — Medtronic announced the launch of the Concerto 3-D Detachable Coil System at the Cardiovascular an
Artventive EOS embolization device, OCCLUDE post-market surveillance study, enrollment

Image courtesy of ArtVentive Medical Group Inc.

News | Embolization devices | February 24, 2016
ArtVentive Medical Group Inc. announced enrollment in the ongoing ArtVentive EOS Endoluminal Occlusion System, OCCLUDE...
Penumbra, POD Packing Coil, embolization, peripheral vasculature
Technology | Embolization devices | January 14, 2016
Penumbra Inc. announced the U.S. launch of its new POD Packing Coil, designed as a complementary device for Penumbra’s...
News | Embolization devices | December 17, 2015
ArtVentive Medical Group conducted its first animal study of its next generation of the ArtVentive Endoluminal...
Merit Medical, QuadraSphere Microspheres, FDA approval, expanding indication, hepatoma

Image courtesy of Merit Medical Systems Inc.

Technology | Embolization devices | August 17, 2015
Merit Medical Systems Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (...
Overlay Init